(Q83390610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Nirupma TrehanPati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Shyam Kotillil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Syed S Hissar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Shikha Shrivastava

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Arshi Khanam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Siddartha K Mishra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Shiv Kumar Sarin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

9 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

509-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21305387%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10875-011-9509-7

22 January 2020

exact match

0 references

cites work

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

1 reference

12 December 2020

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

12 December 2020

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

1 reference

12 December 2020

Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy

1 reference

12 December 2020

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

1 reference

12 December 2020

Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease

1 reference

12 December 2020

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Chronic hepatitis B: current testing strategies.

1 reference

12 December 2020

Antigen-induced regulatory T cells

1 reference

12 December 2020

Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B

1 reference

12 December 2020

Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

1 reference

12 December 2020

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

12 December 2020

Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma

1 reference

12 December 2020

Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil

1 reference

12 December 2020

Natural versus adaptive regulatory T cells

1 reference

12 December 2020

Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection

1 reference

12 December 2020

T-Cell Dysfunction and Inhibitory Receptors in Hepatitis C Virus Infection

1 reference

12 December 2020

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis

1 reference

12 December 2020

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

1 reference

12 December 2020

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

12 December 2020

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

12 December 2020

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

1 reference

12 December 2020

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

1 reference

12 December 2020

Studies of interleukin-12 in chronic hepatitis B virus infection

1 reference

12 December 2020

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

12 December 2020

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

1 reference

12 December 2020

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

12 December 2020

Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?

1 reference

12 December 2020

Viral dynamics in chronic hepatitis B patients during lamivudine therapy

1 reference

12 December 2020

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

12 December 2020

Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B

1 reference

12 December 2020

Interleukin-12 inhibits hepatitis B virus replication in transgenic mice

1 reference

12 December 2020

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

1 reference

12 December 2020

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

12 December 2020

Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection

1 reference

12 December 2020

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

12 December 2020

Antigen-specific regulatory T cells--their induction and role in infection

1 reference

12 December 2020

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

12 December 2020

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir

1 reference

12 December 2020

Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

12 December 2020

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

12 December 2020

Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine

1 reference

12 December 2020

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity

1 reference

12 December 2020

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

1 reference

12 December 2020

"The good, the bad, and the ugly." The role of chemokines in models of human disease.

1 reference

12 December 2020

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

12 December 2020

Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection

1 reference

12 December 2020

Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients

1 reference

12 December 2020

Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B

1 reference

12 December 2020

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

12 December 2020

Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection

1 reference

12 December 2020